{"log_id": 894471060152759326, "direction": 0, "words_result_num": 42, "words_result": [{"probability": {"variance": 5e-06, "average": 0.997446, "min": 0.994315}, "location": {"width": 109, "top": 189, "height": 24, "left": 159}, "words": "【儿童用药】"}, {"probability": {"variance": 2.7e-05, "average": 0.99773, "min": 0.971817}, "location": {"width": 858, "top": 221, "height": 27, "left": 192}, "words": "年龄小于18岁人群使用布托啡诺的有效性和安全性还未证实,所以不推荐小于18岁的人群使用布托"}, {"probability": {"variance": 0, "average": 0.999279, "min": 0.998702}, "location": {"width": 43, "top": 255, "height": 23, "left": 151}, "words": "啡诺"}, {"probability": {"variance": 4e-06, "average": 0.997614, "min": 0.993957}, "location": {"width": 109, "top": 288, "height": 25, "left": 158}, "words": "【老年用药】"}, {"probability": {"variance": 6.4e-05, "average": 0.997308, "min": 0.94735}, "location": {"width": 859, "top": 321, "height": 27, "left": 192}, "words": "在约1500名患者给予布托啡诺注射液的临床研究中,15%的患者年龄超过61岁,1%患者年龄超过"}, {"probability": {"variance": 0, "average": 0.999506, "min": 0.99912}, "location": {"width": 49, "top": 355, "height": 24, "left": 151}, "words": "75岁"}, {"probability": {"variance": 0.004883, "average": 0.987915, "min": 0.514296}, "location": {"width": 857, "top": 387, "height": 27, "left": 192}, "words": "由于清除率的改变,65岁以上患者的布托啡诺平均半衰期增加25%(超过6小时)。老年患者或许对布"}, {"probability": {"variance": 3e-06, "average": 0.99905, "min": 0.994086}, "location": {"width": 221, "top": 421, "height": 25, "left": 151}, "words": "托啡诺的不良反应更敏感"}, {"probability": {"variance": 0.002103, "average": 0.980124, "min": 0.749235}, "location": {"width": 850, "top": 454, "height": 27, "left": 192}, "words": "老年患者布托啡诺注射液的初始推荐给药剂量一般应为成人推荐剂量的一半(0.5mgIV和1.0mgIM)"}, {"probability": {"variance": 4e-06, "average": 0.999019, "min": 0.989735}, "location": {"width": 766, "top": 486, "height": 25, "left": 151}, "words": "应根据患者的反应重复给药,而不是根据固定的时间间隔,但一般时间间隔不少于6小时"}, {"probability": {"variance": 0.001671, "average": 0.991577, "min": 0.728831}, "location": {"width": 850, "top": 518, "height": 28, "left": 191}, "words": "布托啡诺及代谢物主要通过肾脏排泄,因此肾功能不全患者应用本后的中毒性反应风险更大。由于"}, {"probability": {"variance": 1e-06, "average": 0.998957, "min": 0.99634}, "location": {"width": 457, "top": 549, "height": 26, "left": 151}, "words": "老年患者的肾功能很可能下降,因此应谨慎选择剂量"}, {"probability": {"variance": 4e-06, "average": 0.998112, "min": 0.994164}, "location": {"width": 149, "top": 582, "height": 23, "left": 158}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.000326, "average": 0.99226, "min": 0.899994}, "location": {"width": 860, "top": 614, "height": 26, "left": 189}, "words": "1.在使用布托啡诺的同时,使用中枢神经系统抑制药[如:酒精、巴比妥类,镇定剂和抗组胺药]会导"}, {"probability": {"variance": 5.5e-05, "average": 0.996386, "min": 0.967319}, "location": {"width": 899, "top": 645, "height": 27, "left": 149}, "words": "致抑制中枢神经系统的作用加强。当与这些药物合用时,布托啡诺的用量应为最小有效剂量,如果同时给"}, {"probability": {"variance": 0.000125, "average": 0.995417, "min": 0.955369}, "location": {"width": 573, "top": 677, "height": 26, "left": 152}, "words": "予可能增强阿片类药物的作用的药物,则应尽可能地减少给药频率"}, {"probability": {"variance": 0.0084, "average": 0.971939, "min": 0.520416}, "location": {"width": 879, "top": 708, "height": 29, "left": 188}, "words": "2.目前还不能确定与影响肝脏代谢的药物(如:红霉素、茶碱等)合用是否影响布托啡诺的作用,但内"}, {"probability": {"variance": 0.002686, "average": 0.9896, "min": 0.674818}, "location": {"width": 793, "top": 728, "height": 42, "left": 150}, "words": "科医师应提高警惕,两者台用时,或许需要减小布托啡诺的起始剂量并延长给药间隔。"}, {"probability": {"variance": 0.006579, "average": 0.973455, "min": 0.596576}, "location": {"width": 573, "top": 773, "height": 24, "left": 186}, "words": "3.布托啡诺与MA0(单胺氧化酶)抑制剂合用是否相互影响还未证实"}, {"probability": {"variance": 4.3e-05, "average": 0.996352, "min": 0.981694}, "location": {"width": 109, "top": 803, "height": 25, "left": 157}, "words": "【药物过量】"}, {"probability": {"variance": 0.000314, "average": 0.993748, "min": 0.906}, "location": {"width": 860, "top": 836, "height": 24, "left": 188}, "words": "临床表现:布托啡诺药物过量的临床表现大体上与阿片类药物相同。过量的后果随布托啡诺的摄入量"}, {"probability": {"variance": 6e-06, "average": 0.998794, "min": 0.98409}, "location": {"width": 898, "top": 867, "height": 25, "left": 150}, "words": "和个体对阿片类药物作用的反应而改变。最严重的症状为通气不足、心血管机能不全、昏迷和死亡。布托"}, {"probability": {"variance": 3.9e-05, "average": 0.997639, "min": 0.96442}, "location": {"width": 898, "top": 898, "height": 26, "left": 150}, "words": "啡诺的过量或许与多次给药有关。另外,过量的发生也可能是由于布托啡诺的意外或故意误用,特别是幼"}, {"probability": {"variance": 2.1e-05, "average": 0.997447, "min": 0.985513}, "location": {"width": 160, "top": 928, "height": 25, "left": 151}, "words": "儿在家中获得药物"}, {"probability": {"variance": 1e-06, "average": 0.999256, "min": 0.994839}, "location": {"width": 859, "top": 961, "height": 25, "left": 190}, "words": "治疗:怀疑布托啡诺使用过量的处理措施包括保持充分的通气,静脉输液和保持正常的体温,以及保"}, {"probability": {"variance": 6.9e-05, "average": 0.996331, "min": 0.952752}, "location": {"width": 899, "top": 992, "height": 26, "left": 150}, "words": "持呼吸道通畅。应采取足够的措施连续观察患者的精神状态、应答性和生命体征。使用氧气和通气辅助设"}, {"probability": {"variance": 5.2e-05, "average": 0.997129, "min": 0.962632}, "location": {"width": 899, "top": 1025, "height": 26, "left": 149}, "words": "备,如果需要应该用脉氧计连续监测。如果患者昏迷,应进行气管插管。应保持适当的静脉通道,以便于"}, {"probability": {"variance": 1e-06, "average": 0.99956, "min": 0.995885}, "location": {"width": 239, "top": 1057, "height": 24, "left": 150}, "words": "治疗血管舒张引起的低血压"}, {"probability": {"variance": 0.000547, "average": 0.994196, "min": 0.844813}, "location": {"width": 858, "top": 1088, "height": 25, "left": 189}, "words": "应该考虑使用特殊的阿片类拮抗剂,如纳洛酮治疗。由于布托啡诺的作用持续时间通常超过纳洛酮的"}, {"probability": {"variance": 1e-06, "average": 0.998891, "min": 0.995537}, "location": {"width": 359, "top": 1120, "height": 24, "left": 150}, "words": "作用持续时间,或许需要重复给予纳洛酮"}, {"probability": {"variance": 4e-06, "average": 0.998434, "min": 0.992214}, "location": {"width": 616, "top": 1152, "height": 25, "left": 188}, "words": "在处理疑似布托啡诺过量服用的情况时,应考虑多次给药所致的可能性"}, {"probability": {"variance": 2.5e-05, "average": 0.997287, "min": 0.986262}, "location": {"width": 109, "top": 1184, "height": 23, "left": 155}, "words": "【药理毒理】"}, {"probability": {"variance": 0, "average": 0.999155, "min": 0.998898}, "location": {"width": 81, "top": 1216, "height": 24, "left": 150}, "words": "药理作用"}, {"probability": {"variance": 0.013979, "average": 0.960368, "min": 0.370806}, "location": {"width": 839, "top": 1248, "height": 26, "left": 189}, "words": "布托啡诺对μ-阿片类(吗啡类)受体具有低内在活性的混合激动拮抗剂。它也是一阿片受体激动剂"}, {"probability": {"variance": 0.000132, "average": 0.995445, "min": 0.923698}, "location": {"width": 899, "top": 1279, "height": 28, "left": 149}, "words": "它与CNS(中枢神经系统)中的这些受体的相互作用间接发挥其药理作用,包括镇痛作用。除镇痛作用"}, {"probability": {"variance": 0.003404, "average": 0.981606, "min": 0.664225}, "location": {"width": 894, "top": 1312, "height": 25, "left": 150}, "words": "外,CNS的作用还包括抑制自发呼吸活动和咳嗽、刺激催吐中枢、缩瞳和镇静。其作用可能是通过非CNS"}, {"probability": {"variance": 5.8e-05, "average": 0.996781, "min": 0.962407}, "location": {"width": 897, "top": 1344, "height": 26, "left": 150}, "words": "作用机制实现的,如改变心血管(神经)的电阻和电容、支气管肌张力、胃肠道分泌和运动活动及膀胱括约"}, {"probability": {"variance": 0, "average": 0.999368, "min": 0.998649}, "location": {"width": 83, "top": 1376, "height": 23, "left": 147}, "words": "肌的活动"}, {"probability": {"variance": 1.2e-05, "average": 0.998116, "min": 0.982333}, "location": {"width": 860, "top": 1403, "height": 25, "left": 188}, "words": "在动物模型中,拮抗吗啡镇痛作用50%所需要的酒石酸布托啡诺的剂量与烯丙吗啡相似,少于喷他佐"}, {"probability": {"variance": 0.000118, "average": 0.9924, "min": 0.969084}, "location": {"width": 157, "top": 1435, "height": 24, "left": 150}, "words": "辛,而多于纳洛酮"}, {"probability": {"variance": 4e-06, "average": 0.998707, "min": 0.990162}, "location": {"width": 859, "top": 1467, "height": 27, "left": 188}, "words": "还没有在人体中研究酒石酸布托啡诺代谢物的药理活性;动物研究已经证明酒石酸布托啡诺代谢物具"}, {"probability": {"variance": 1e-06, "average": 0.999271, "min": 0.997826}, "location": {"width": 162, "top": 1501, "height": 23, "left": 149}, "words": "有一定的镇痛作用"}], "language": 3}